Disease/Infection News

RSS

AHF's Magic Johnson Testing America Tour arrives in Nashua, New Hampshire to offer free HIV testing

AHF's Magic Johnson 'Testing America' Tour, a six month, 48 state national cross country HIV testing tour, arrives in Nashua, New Hampshire tomorrow and will offer free HIV testing, along with local partner Southern New Hampshire AIDS Task Force from 3:00 PM to 7:00 PM at the Greeley Park 2010 Music and Film Festival, 105 Concord Street.

19 Jun 2010

Recent releases in Global Health

The U.N.'s plan to improve maternal health is lacking "the one element that will make it work. Human rights," according to blog post on Huffington Post. "Medical causes of maternal death - hemorrhage, sepsis, hypertension, unsafe abortion, HIV and AIDS - are inextricably linked to human rights. Each one of these instances can be prevented or treated by simply respecting women's human rights in health policies and delivery of services, and addressing systemic gender inequality."

19 Jun 2010

Research on evolution of malaria parasite to develop improved control strategies

An international team, led by researchers at Imperial College London, have found that the potentially deadly tropical disease evolved alongside anatomically modern humans and moved with our ancestors as they migrated out of Africa around 60-80,000 years ago. The research is published in the journal Current Biology.

18 Jun 2010

Antwerp ITM calls for change in WHO guidelines on Buruli ulcer

Buruli ulcers, one of the 'neglected tropical diseases' left aside by big pharma and governments alike, are reasonably well treatable, also in poor regions. But then more attention has to be paid to early diagnosis and correct treatment. This means the rules of the World Health Organization urgently need to be changed. So say scientists of the Antwerp Institute of Tropical Medicine (ITM), based on ten years of research in Congo.

18 Jun 2010

90% of HCV patients to be treated with triple therapy regimens, finds Decision Resources

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, based on clinical profiles provided to them, surveyed clinicians estimate that one year after the launch of Vertex Pharmaceuticals/Johnson & Johnson/Mitsubishi Tanabe Pharma's telaprevir and Merck's boceprevir, at least 90 percent of hepatitis C virus patients will be treated with triple therapy regimens.

18 Jun 2010

New multimillion dollar BSL-3 laboratory complex at Nigerian National TB and Leprosy Training Center

This week, the U.S. Centers for Disease Control (CDC) Director, Dr. Tom Frieden, visited the Nigerian National TB and Leprosy Training Center (NTBLTC) to tour a multimillion dollar laboratory complex established by the Institute of Human Virology (IHV) of the University of Maryland School of Medicine in Baltimore, Maryland, and the Institute of Human Virology-Nigeria. This U.S.-Nigeria partnership was established in 2004 through funding from the CDC and the President's Emergency Plan For AIDS Relief (PEPFAR).

18 Jun 2010

Nurse-monitored ART found to be as safe, effective as therapy monitored by doctors in South African trial

"HIV drugs can be administered as effectively by nurses as by doctors, a finding that could yield major benefits in the fight against AIDS in Africa," according to a study published online Wednesday in the Lancet, Agence France-Presse reports.

18 Jun 2010

NPR's Morning Edition examines Global Health Initiative

NPR's Morning Edition examines the Obama administration's Global Health Initiative (GHI) and efforts to combat HIV/AIDS. The $63 billion dollar "initiative preserves the Bush AIDS relief plan," known as PEPFAR, and aims "to allow patients to get care at one location rather than having to seek care at different places. For example, family planning at one facility and HIV care at another," NPR notes.

18 Jun 2010

UF administers Lumizyme for late-onset Pompe disease

The first commercially available treatment in the United States for patients with late-onset Pompe disease was administered Wednesday, June 16, at the University of Florida.

18 Jun 2010

Elderly people in sub-Saharan Africa remain neglected as a result of AIDS epidemic: Researchers

The rise in AIDS death rates in sub-Saharan Africa has led to a burgeoning new category of neglected individuals - nearly a million orphaned elderly, or older adults living alone without the benefit of any caregivers, Stanford University School of Medicine researchers have found.

18 Jun 2010

Experts discuss G8 aid commitments

Economist Jeffrey Sachs said Wednesday that the G8 could endanger its credibility if leaders fail to fulfill several "broken multi-billion-dollar pledges" aimed at helping the developing world, Canwest News Service/Vancouver Sun reports.

18 Jun 2010

Fraudulent Tamiflu sold over Internet, FDA warns

The U.S. Food and Drug Administration today warned consumers about a potentially harmful product represented as "Generic Tamiflu" sold over the Internet. FDA tests revealed that the fraudulent product does not contain Tamiflu's active ingredient, oseltamivir, but cloxacillin, an ingredient in the same class of antibiotics as penicillin.

18 Jun 2010

Study evaluates effect of Viusid on oxidative stress, cytokine parameters in patients with CHC

The pathogenesis of chronic hepatitis C is associated with severe oxidative stress and non-selective immunological disturbance that lead to necroinflammation and the progression of fibrosis. Several trials have suggested that antioxidant and immunostimulant therapies may have a beneficial effect. Two previous clinical studies have reported that the Viusid related effect on histologic features, especially fibrosis, appears to be associated with antioxidant and/or immunomodulatory properties.

18 Jun 2010

Malaria rises as forests disappear: Study

Avid deforestation of the tropical forests is cited to be one of the reasons for the 50% increase in incidence of this disease in the surrounding areas according to a new research that is tracking deforestation in Brazil's Amazon.

18 Jun 2010

Biological mechanism associated with remission during pregnancy

During pregnancy, many women experience remission of autoimmune diseases like multiple sclerosis and uveitis. Now, scientists have described a biological mechanism responsible for changes in the immune system that helps to explain the remission.

17 Jun 2010

Constipation prophylaxis in sickle cell patients needs increased attention

Not all patients with sickle cell disease receive laxatives after being treated with narcotics, despite recommendations from a collaborative panel of pediatric experts. These are the findings from a Nationwide Children's Hospital study examining patients from 29 pediatric hospitals, and appearing in Pediatric Blood & Cancer.

17 Jun 2010

2009 H1N1 pandemic influenza vaccine protects against 1918 influenza virus: Report

Mice injected with a 2009 H1N1 pandemic influenza vaccine and then exposed to high levels of the virus responsible for the 1918 influenza pandemic do not get sick or die, report scientists funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

17 Jun 2010

Kun Run Biotechnology obtains China SFDA manufacturing approval for Entecavir

Kun Run Biotechnology, Inc., a leading bio-pharmaceutical company in China focusing on manufacturing and sales of peptide-based and small molecule drugs, today announced that they have obtained the manufacturing approval for Entecavir from the China State Food and Drug Administration (SFDA).

17 Jun 2010

Scientific American publishes article on "rebirth" of DNA vaccines

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Scientific American magazine has published in its July issue an article entitled "DNA Drugs Come of Age." The article was co-authored by Dr. David Weiner, Chairman, Scientific Advisory Board, Inovio Pharmaceuticals, and Professor, Department of Pathology & Laboratory Medicine, at the University of Pennsylvania and Dr. Matthew Morrow, a post-doctorate research fellow at University of Pennsylvania.

17 Jun 2010

Infant nevirapine more effective in preventing HIV transmission than maternal antiretroviral therapy

The largest study to date to examine methods to prevent HIV infection among breastfeeding infants concludes that giving antiretroviral drugs to HIV-infected breastfeeding mothers in sub-Saharan Africa or giving an HIV-fighting syrup to their babies are both effective.

17 Jun 2010

Disease/Infection News

AHF's Magic Johnson Testing America Tour arrives in Nashua, New Hampshire to offer free HIV testing

Recent releases in Global Health

Research on evolution of malaria parasite to develop improved control strategies

Antwerp ITM calls for change in WHO guidelines on Buruli ulcer

90% of HCV patients to be treated with triple therapy regimens, finds Decision Resources

New multimillion dollar BSL-3 laboratory complex at Nigerian National TB and Leprosy Training Center

Nurse-monitored ART found to be as safe, effective as therapy monitored by doctors in South African trial

NPR's Morning Edition examines Global Health Initiative

UF administers Lumizyme for late-onset Pompe disease

Elderly people in sub-Saharan Africa remain neglected as a result of AIDS epidemic: Researchers

Experts discuss G8 aid commitments

Fraudulent Tamiflu sold over Internet, FDA warns

Study evaluates effect of Viusid on oxidative stress, cytokine parameters in patients with CHC

Malaria rises as forests disappear: Study

Biological mechanism associated with remission during pregnancy

Constipation prophylaxis in sickle cell patients needs increased attention

2009 H1N1 pandemic influenza vaccine protects against 1918 influenza virus: Report

Kun Run Biotechnology obtains China SFDA manufacturing approval for Entecavir

Scientific American publishes article on "rebirth" of DNA vaccines

Infant nevirapine more effective in preventing HIV transmission than maternal antiretroviral therapy

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News